Jyong Biotech Ltd. Ordinary Shares (MENS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - |
| Cost of Goods Sold | 58K | 0 | 62K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - |
| Gross Profit | -58K | 0 | -62K | 0 | 0 |
| Gross Margin % | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - |
| Operating Expenses | 553 | 553 | 476 | 476 | 844 |
| OpEx % of Revenue | - | - | - | - | - |
| Selling, General & Admin | 339 | 339 | 226 | 226 | 578 |
| SG&A % of Revenue | - | - | - | - | - |
| Research & Development | 214 | 214 | 250 | 250 | 267 |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -553 | -553 | -476 | -476 | -844 |
| Operating Margin % | - | - | - | - | - |
| Operating Income Growth % | 34.54% | - | - | - | - |
| EBITDA | -524 | -524 | -445 | -445 | -813 |
| EBITDA Margin % | - | - | - | - | - |
| EBITDA Growth % | 35.61% | - | - | - | - |
| D&A (Non-Cash Add-back) | 29 | 29 | 31 | 31 | 31 |
| EBIT | -553 | -553 | -476 | -476 | -844 |
| Net Interest Income | -293 | -293 | -221 | -221 | -172 |
| Interest Income | 1K | 0 | 6K | 0 | 0 |
| Interest Expense | 587K | 293 | 448K | 221 | 172 |
| Other Income/Expense | -294 | -294 | -188 | -188 | -485 |
| Pretax Income | -847 | -847 | -663 | -663 | -1.33K |
| Pretax Margin % | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% |
| Net Income | -847 | -847 | -663 | -663 | -1.33K |
| Net Margin % | - | - | - | - | - |
| Net Income Growth % | 36.31% | - | - | - | - |
| Net Income (Continuing) | -847 | -847 | -663 | -663 | -1.33K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Growth % | 36.56% | - | - | - | - |
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Diluted Shares Outstanding | 71.57K | 71.57K | 71.57K | 71.57K | 71.57K |
| Basic Shares Outstanding | 71.57K | 71.57K | 71.57K | 71.57K | 71.57K |
| Dividend Payout Ratio | - | - | - | - | - |